Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Biguanides Market, by Region, 2019-2029 (USD Billion)
1.2.2. Biguanides Market, by Type, 2019-2029 (USD Billion)
1.2.3. Biguanides Market, by Dosage Form, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biguanides Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biguanides Market Dynamics
3.1. Biguanides Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising cases of diabetic patients
3.1.1.2. Growing healthcare expenditure
3.1.2. Market Challenges
3.1.2.1. Threat of substitute
3.1.3. Market Opportunities
3.1.3.1. Technological innovations and advancements
3.1.3.2. Growing usage of anti-biotic drugs
Chapter 4. Global Biguanides Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Biguanides Market, by Type
6.1. Market Snapshot
6.2. Global Biguanides Market by Type, Performance – Potential Analysis
6.3. Global Biguanides Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Biguanides Market, Sub Segment Analysis
6.4.1. Metformin IR,
6.4.2. Metformin ER,
6.4.3. Other Biguanide
Chapter 7. Global Biguanides Market, by Dosage Form
7.1. Market Snapshot
7.2. Global Biguanides Market by Dosage Form, Performance – Potential Analysis
7.3. Global Biguanides Market Estimates & Forecasts by Dosage Form 2019-2029 (USD Billion)
7.4. Biguanides Market, Sub Segment Analysis
7.4.1. Tablets
7.4.2. Solution
Chapter 8. Global Biguanides Market, Regional Analysis
8.1. Biguanides Market, Regional Market Snapshot
8.2. North America Biguanides Market
8.2.1. U.S. Biguanides Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Dosage Form breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Biguanides Market
8.3. Europe Biguanides Market Snapshot
8.3.1. U.K. Biguanides Market
8.3.2. Germany Biguanides Market
8.3.3. France Biguanides Market
8.3.4. Spain Biguanides Market
8.3.5. Italy Biguanides Market
8.3.6. Rest of Europe Biguanides Market
8.4. Asia-Pacific Biguanides Market Snapshot
8.4.1. China Biguanides Market
8.4.2. India Biguanides Market
8.4.3. Japan Biguanides Market
8.4.4. Australia Biguanides Market
8.4.5. South Korea Biguanides Market
8.4.6. Rest of Asia Pacific Biguanides Market
8.5. Latin America Biguanides Market Snapshot
8.5.1. Brazil Biguanides Market
8.5.2. Mexico Biguanides Market
8.6. Rest of The World Biguanides Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Teva
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Merck
9.2.3. Takeda
9.2.4. GlaxoSmithKline
9.2.5. Sanofi
9.2.6. Boehringer Ingelheim Pharmaceuticals
9.2.7. Glenmark
9.2.8. AstraZeneca
9.2.9. Bristol-Myers Squibb
9.2.10. Aarti Drugs Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption